These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 4790306)

  • 1. [Lymphocyte transformation by phytohemagglutinin P in multiple sclerosis patients].
    Hierholzer E; Kuwert E
    Verh Dtsch Ges Inn Med; 1973; 79():602-6. PubMed ID: 4790306
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lymphocyte sensitivity to phytohemagglutin (PHA) and pokeweed mitogen (PWM) in patients with multiple sclerosis].
    Czernicki J; Chmielewski H; Jurkowski A
    Pol Tyg Lek; 1974 May; 29(21):881-3. PubMed ID: 4840200
    [No Abstract]   [Full Text] [Related]  

  • 3. [Transformation of lymphocytes of patients with multiple sclerosis, after treatment in vitro with phytoagglutinins].
    Becuş T; Gyargyay-Malatinski E; Kovács V
    Neurol Psihiatr Neurochir; 1973; 18(4):367-75. PubMed ID: 4356513
    [No Abstract]   [Full Text] [Related]  

  • 4. [Plant agglutinin- and PPD tuberculin-stimulated lymphocyte transformation in vitro in patients with disseminated sclerosis].
    Cendrowski W; Moskalewska K; Plonka T; Niedzielska K
    Neurol Neurochir Pol; 1971; 5(4):485-8. PubMed ID: 4330664
    [No Abstract]   [Full Text] [Related]  

  • 5. A humoral lymphocyte transformation inhibition factor in multiple sclerosis.
    Wernicke JF; Sweet PM; van den Noort S; Mayberg HS; Armentrout SA
    J Clin Lab Immunol; 1983 Dec; 12(4):187-95. PubMed ID: 6198521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.
    Krumbholz M; Theil D; Cepok S; Hemmer B; Kivisäkk P; Ransohoff RM; Hofbauer M; Farina C; Derfuss T; Hartle C; Newcombe J; Hohlfeld R; Meinl E
    Brain; 2006 Jan; 129(Pt 1):200-11. PubMed ID: 16280350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-mediated immunity in multiple sclerosis.
    Espinoza LR; Ebers G; Mountcastle W; Zabriskie JB
    Acta Neurol Scand Suppl; 1977; 63():123-31. PubMed ID: 265663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinico-immunologic correlations in disseminated sclerosis].
    Zavalishin IA; Khondkarian OA; Nevskaia OM; Pivovarova AI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(2):164-7. PubMed ID: 6608842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lymphocyte transformation in multiple sclerosis. Demonstration of cell sensitivity to basic myelin protein (author's transl)].
    Frick E; Stickl H; Zinn KH
    Klin Wochenschr; 1974 Mar; 52(5):238-45. PubMed ID: 4835640
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasmapheresis, lymphocytapheresis, and immunosuppressive drug therapy in multiple sclerosis.
    Hauser SL; Fosburg M; Kevy S; Weiner HL
    Prog Clin Biol Res; 1982; 106():239-54. PubMed ID: 6184727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on immunological responsiveness of cancer patients. I. Standardization of phytohemagglutinin-stimulated lymphocyte transformation].
    Kumashiro R
    Fukuoka Igaku Zasshi; 1976 Sep; 67(9):331-8. PubMed ID: 1033894
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter: Effect of prednisolone on lymphocyte transformation in multiple sclerosis.
    Biggins JA; Caspary EA
    Lancet; 1975 Mar; 1(7908):686. PubMed ID: 47112
    [No Abstract]   [Full Text] [Related]  

  • 13. Defective immunoregulation in multiple sclerosis.
    Goust JM; Hoffman PM; Pryjma J; Hogan EL; Fudenberg HH
    Ann Neurol; 1980 Nov; 8(5):526-33. PubMed ID: 7436394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocytapheresis in multiple sclerosis: a preliminary report.
    Giordano GF; Masland W; Ketchel SJ; Holland K; Tilmann K; Wallace BA; DeGreen HP; Tenser R; Kasprisin D; Hamburger M; Rosen A; Pitts W
    Prog Clin Biol Res; 1982; 106():255-62. PubMed ID: 7178138
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
    Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
    Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blastic transformation of lymphocytes induced with phytohemagglutinin in patients with rheumatoid arthritis].
    Celińska-Szpytko E; Mackiewicz S
    Pol Tyg Lek; 1974 May; 29(19):769-70. PubMed ID: 4848142
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of phytohemagglutinin-induced in vitro lymphocyte transformation by serum from patients with carcinoma.
    Sample WF; Gertner HR; Chretien PB
    J Natl Cancer Inst; 1971 Jun; 46(6):1291-7. PubMed ID: 5088049
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T.
    Srinivasan R; Sailasuta N; Hurd R; Nelson S; Pelletier D
    Brain; 2005 May; 128(Pt 5):1016-25. PubMed ID: 15758036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical demyelination and diffuse white matter injury in multiple sclerosis.
    Kutzelnigg A; Lucchinetti CF; Stadelmann C; Brück W; Rauschka H; Bergmann M; Schmidbauer M; Parisi JE; Lassmann H
    Brain; 2005 Nov; 128(Pt 11):2705-12. PubMed ID: 16230320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Classification of multiple sclerosis].
    Khondkarian OA; Zavalishin IA; Nevskaia OM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(2):164-6. PubMed ID: 6858474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.